TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 11,648 | 12,784 | 10,854 |
Financial expenses | 162 | 38 | 40 |
Earnings before taxes | -2,274 | -1 | 1,324 |
EBITDA | -1,299 | 1,173 | 2,249 |
Total assets | 18,700 | 16,997 | 15,785 |
Current assets | 6,381 | 7,158 | 7,276 |
Current liabilities | 6,394 | 3,602 | 2,888 |
Equity capital | 12,158 | 9,700 | 10,183 |
- share capital | 13 | 15 | 15 |
Employees (average) | 75 | 66 | 56 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 65.0% | 57.1% | 64.5% |
Turnover per employee | 155 | 194 | 194 |
Profit as a percentage of turnover | -19.5% | 0.0% | 12.2% |
Return on assets (ROA) | -11.3% | 0.2% | 8.6% |
Current ratio | 99.8% | 198.7% | 251.9% |
Return on equity (ROE) | -18.7% | 0.0% | 13.0% |
Change turnover | |||
Change turnover % | 20% | ||
Chg. No. of employees | |||
Chg. No. of employees % | 18% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.